Showing results (251-260 of 1,142) with videos related to
Sort By:
Pageof 115
Seminars in Liver Disease|March 13, 2025
Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver FailureJulian Pohl, Dimitrios Aretakis, Frank Tacke, et al.Deutsche Medizinische Wochenschrift (1946)|December 4, 2018
[Current Developments in Nutritional Therapy of Intensive Care Patients]Alexander Koch, Lukas Bündgens, Ulf Herbers, et al.JHEP Reports : Innovation in Hepatology|July 21, 2025
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver diseaseRobert F Schwabe, Frank Tacke, Atsushi Sugimoto, et al.Clinical and Molecular Hepatology|June 9, 2025
Prospects of Mendelian randomization in hepatology: a comprehensive literature review with practice guidanceLanlan Chen, Qi Rao, Menghan Gao, et al.Journal of Inflammation Research|March 20, 2026
The Role of Galectin-3 in Liver Inflammation and FibrosisIsabella Lurje, Dina Katharina Biegel, Ingrid Wei Zhang, et al.Egastroenterology|December 31, 2025
Engineering liver disease models in vitro: emerging trends and innovationsQi Rao, Lei Wang, Frank Tacke, et al.Gastroenterology Report|April 7, 2025
Management of IgG4-related cholangitis: diagnosis, therapy, and long-term surveillanceToni Herta, Maik Schröder, Dominik Geisel, et al.International Journal of Molecular Sciences|July 2, 2021
The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary MalignanciesBurcin Özdirik, Tobias Müller, Alexander Wree, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 25, 2022
Real-life experiences with bulevirtide for the treatment of hepatitis delta-48 weeks data from a German centreCaroline Zöllner, Jörg Hofmann, Katrin Lutz, et al.Expert Review of Gastroenterology & Hepatology|December 17, 2008
Chemokine-directed immune cell infiltration in acute and chronic liver diseaseKarlin Raja Karlmark, Hermann E Wasmuth, Christian Trautwein, et al.Pageof 115